GAG
REGN icon

Goodman Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Goodman Advisory Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$962 – 206
2024
Q1 		$962 Buy
+1
New +$951 ﹤0.01% 163
2023
Q2 		– Sell
-298
Closed -$245K – 179
2023
Q1 		$245K Sell
298
-412
-58% -$311K 0.13% 44
2022
Q4 		$512K Hold
710
– – 0.3% 35
2022
Q3 		$489K Sell
710
-179
-20% -$113K 0.27% 36
2022
Q2 		$526K Sell
889
-6,287
-88% -$4.09M 0.23% 33
2022
Q1 		$5.01M Sell
7,176
-1,002
-12% -$634K 1.73% 20
2021
Q4 		$5.17M Buy
+8,178
New +$5.03M 1.74% 21

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return